Roche Gets Additional FDA Nod for HIV, Hepatitis Test
December 02, 2009
Roche Gets Additional FDA Nod for HIV, Hepatitis Test
The FDA approved an additional intended use for Roche's licensed Cobas TaqScreen MPX nucleic acid test to screen donated source plasma.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 25, 2011 / PCR Insider - NEJM Study of Gen-Probe Assay Backs Use of Triplex NAT in HBV Blood Screening
January 20, 2011 / PCR Insider - PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider - Cepheid Provides Update on MDx Pipeline with Focus on CT/NG, TB, Oncology
September 20, 2012 / PCR Insider - Iquum Gets FDA OK for Flu A/B Test; Eyes More Assays for Its Automated MDx System
August 25, 2011 / PCR Insider